ARA-290 (Cibinetide, 11-mer EPO-derived peptide): Mechanism, Benefits & Research Evidence

Class & Mechanism — ARA-290 is an 11-amino acid peptide derived from erythropoietin (EPO) with neuroprotective properties and the potential to reduce inflammation.
Research-documented benefitsLocal corpus: silent.
General-knowledge benefits — ARA-290 is being investigated for its potential in treating neurological disorders and reducing inflammation.
Typical injectable protocol — Research-only, experimental. Dosing information is not available in the provided excerpts.
Key risks / contraindications — No specific risks mentioned in the provided excerpts.
Bottom line — ARA-290 is a peptide with potential neuroprotective effects, but its use in humans requires further research.

References

  1. Antimicrobial Peptides and Human Disease
  2. Antimicrobial Peptides_ Basics for Clinical Application
  3. Antimicrobial peptides and the skin immune defense system
  4. Antimicrobial peptides from plants with potential against multidrug-resistant bacteria
  5. Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
  6. Click Chemistry_ A Universal Ligation Strategy
  7. GHK Peptide as a Natural Modulator of Multiple Cellular — Loren Pickart
  8. Handbook of Biologically Active Peptides
  9. Kosmetik für Ärzte und Apotheker
  10. Life Force
  11. Living a Fully Optimized Life
  12. Mechanisms of Photoaging and Cutaneous Photocarcinogenesis
  13. Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
  14. Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
  15. Peptide Protocols Volume One — William A Seeds MD
  16. Peptide therapy with pentadecapeptide BPC 157 in traumatic — Gjurasin, Miroslav
  17. Rook's Textbook of Dermatology
  18. The effect of pentadecapeptide BPC 157, H-blockers — Predrag Sikiric
  19. The pharmacological properties of the novel peptide BPC 157 — P Sikiric(Affiliation Department of Pharmacology, Medical
  20. Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor